Rosiglitazone: a new therapy for Type 2 diabetes

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.10, 1999-10, pp. : 1709-1719

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosiglitazone plus metformin: combination therapy for Type 2 diabetes

By Del Prato Stefano Volpe Laura

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1411-1422

Informa Healthcare

Access to resources Recommend Favorite

The sweet and sour RECORD of rosiglitazone for type 2 diabetes

Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Sitagliptin tops rosiglitazone for type 2 diabetes

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Sitagliptin tops rosiglitazone for type 2 diabetes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Retrospective Analysis of Rosiglitazone and Macular Oedema in Patients with Type 2 Diabetes Mellitus

By Tatti Patrizio

Clinical Drug Investigation, Vol. 28, Iss. 5, 2008-01 ,pp. : 327-332

Adis International

Access to resources Recommend Favorite